Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Microcirculation. 2011 Jan;18(1):36–45. doi: 10.1111/j.1549-8719.2010.00066.x

Figure 2.

Figure 2

Effect of L-arginine administration and arginase inhibition on vasomotor function. Coronary arteriolar dilation to serotonin (Control; n=14) was inhibited by OxLDL (0.5 mg protein/ml; n=5). Administration of L-arginine (L-Arg, 3 mM; n=4) or arginase inhibitor DFMO (0.4 mM; n=5) restored vasodilation to serotonin. *P<0.05 vs. Control.